The SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship from the Society for Immunotherapy of Cancer (SITC) with funding from Bristol Myers Squibb, supports the development of the next generation of immunotherapy experts. Applicants must hold an MD, PhD or combined MD/PhD degree and have a vested interest in furthering the research and translation of cancer immunotherapy. Applicants must be a member of the SITC. Applications are open to candidates worldwide. The fellowship provides funding of 200,000 USD over two years plus complimentary registration and travel for SITC’s 38th Annual Meeting.
Applications close on March 27, 2023.